These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 23892448

  • 1. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 2. Variation in genes in the endothelin pathway and endothelium-dependent and endothelium-independent vasodilation in an elderly population.
    Lind L, Syvänen AC, Axelsson T, Lundmark P, Hägg S, Larsson A.
    Acta Physiol (Oxf); 2013 May; 208(1):88-94. PubMed ID: 23336501
    [Abstract] [Full Text] [Related]

  • 3. L-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
    Lind L, Larsson A, Teerlink T.
    Atherosclerosis; 2009 Apr; 203(2):544-9. PubMed ID: 18757055
    [Abstract] [Full Text] [Related]

  • 4. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 5. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.
    J Appl Physiol (1985); 2007 Jan 01; 102(1):63-71. PubMed ID: 16946027
    [Abstract] [Full Text] [Related]

  • 6. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
    Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, de Andrade MF, Molina CAF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R.
    Nitric Oxide; 2019 Nov 01; 92():11-17. PubMed ID: 31394201
    [Abstract] [Full Text] [Related]

  • 7. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
    Amir M, Hassanein SI, Abdel Rahman MF, Gad MZ.
    Mol Biol Rep; 2018 Dec 01; 45(6):2411-2419. PubMed ID: 30284143
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF, Garbin U, Stranieri C, Boccioletti V, Mozzini C, Manfro S, Pasini A, Cominacini M, Cominacini L.
    Am J Hypertens; 2008 Nov 01; 21(11):1251-7. PubMed ID: 18772860
    [Abstract] [Full Text] [Related]

  • 9. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul 01; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 10. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 01; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 11. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
    Saarelainen H, Valtonen P, Punnonen K, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S.
    Clin Physiol Funct Imaging; 2008 Mar 01; 28(2):120-4. PubMed ID: 18093231
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the estrogen receptor alpha gene and endothelial function in resistance and conduit arteries in the elderly.
    Ingelsson E, Syvänen AC, Lind L.
    Atherosclerosis; 2008 Jul 01; 199(1):162-71. PubMed ID: 18062975
    [Abstract] [Full Text] [Related]

  • 13. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 01; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 14. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting MJ, Craig JE, Burdon KP.
    J Diabetes Complications; 2012 Aug 01; 26(3):195-8. PubMed ID: 22521321
    [Abstract] [Full Text] [Related]

  • 15. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Aug 01; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 16. Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
    Wu CC, Hsieh MY, Lee CK, Chuang SY, Chung MY, Lin CC.
    Am J Nephrol; 2019 Aug 01; 50(6):454-464. PubMed ID: 31639806
    [Abstract] [Full Text] [Related]

  • 17. Vasodilation and visceral fat in elderly subjects: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
    Lind L, Johansson L, Hulthe J, von Below C, Ahlström H.
    Atherosclerosis; 2007 Oct 01; 194(2):e64-71. PubMed ID: 17157860
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan 01; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 19. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.
    Atherosclerosis; 2014 Nov 01; 237(1):38-44. PubMed ID: 25194333
    [Abstract] [Full Text] [Related]

  • 20. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
    Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, Mills RA, Craig JE.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1923-7. PubMed ID: 22395885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.